Skip to content

AI-based longitudinal monitoring of the dialysis shunt using smartphone-generated audio data: ShuntMerlin

AI-based longitudinal monitoring of the dialysis shunt using smartphone-generated audio data: ShuntMerlin - ShuntMerlin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040394
Enrollment
100
Registered
2026-06-02
Start date
2026-05-19
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease, ESRD

Interventions

Group 1: The ShuntMerlin study is a multicenter, non-interventional observational study investigating the correlation between smartphone-based audio recordings of dialysis shunts and sonographic findi

Sponsors

Universitätsklinikum Augsburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Legally competent patients who have been informed about the study in written and oral form and have provided informed consent to participate. Women and men over 18 years of age with a native forearm arteriovenous shunt (so-called Cimino fistula/radiocephalic AV fistula), either left- or right-sided.

Exclusion criteria

Exclusion criteria: Patients with prosthetic shunts (e.g., PTFE grafts, AngioSeal®, Goretex®). Patients with left ventricular assist devices (LVADs). Patients with severe valvular heart disease. Dependent patients under care.

Design outcomes

Primary

MeasureTime frame
Primary endpoint: Detection of shunt dysfunction What: Detection of a clinically relevant shunt dysfunction (stenosis, reduced blood flow, or thrombosis), confirmed by ultrasound (gold standard). When: Continuously throughout the study; event-driven at the time of clinical diagnosis or required intervention, as well as at predefined follow-up time points or during dialysis sessions. How: Smartphone audio recordings of the shunt (10–30 s, once weekly, using a standardized app and measurement site) with AI-based analysis; comparison with clinical routine diagnostics (duplex ultrasound, possibly angiography) and documentation by the vascular medicine/nephrology team.

Secondary

MeasureTime frame
Secondary endpoints: -Patient-Reported Outcomes (PROs) What: Patient satisfaction and perceived safety in managing the vascular access (shunt) and the monitoring system. How measured: Using validated questionnaires (PHQ-9 and WHOQOL-100), as well as additional items assessing perceived safety, usability, and satisfaction with the smartphone-based shunt monitoring system. -Adherence to measurements What: Reliability of patients in performing the smartphone-based shunt recordings. How measured: Proportion of completed recordings compared to scheduled recordings, based on app log data (timestamps, completeness of recordings).

Countries

Germany

Contacts

Public ContactAlexander Hyhlik-Dürr

Universitätsklinikum Augsburg

alexander.hyhlik-duerr@uk-augsburg.de+49 821400 2655

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 29, 2026